# INMAZEB
> **BLA761169** · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2020-10-14
## Drug
- **FDA Application Number:** BLA761169
- **Application type:** Biologics License Application
- **Brand name:** INMAZEB
- **Generic name:** ATOLTIVIMAB, MAFTIVIMAB, AND ODESIVIMAB-EBGN
- **Active ingredients:** ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** REGENERON PHARMACEUTICALS
- **Manufacturer:** Regeneron Pharmaceuticals, Inc.
- **First approval:** 2020-10-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761169)
---
*AI Analytics · CC0 1.0*